PerkinElmer separates Life Sciences business

Test tube in laboratory

PerkinElmer has successfully completed the divestiture of its Applied, Food and Enterprise Services businesses to New Mountain Capital.

The resulting new Life Sciences and Diagnostics business will share the PerkinElmer name until a new name, brand and ticker symbol is unveiled in Q2 2023 pending shareholder approval.

“Today marks the culmination of the hard work and dedication from PerkinElmer teams around the world to ensure that both new companies are in a position to succeed on day one,” said Prahlad Singh, President and Chief Executive Officer of the PerkinElmer Life Sciences and Diagnostics company.

“I’m looking forward to sharing our new name and brand in the near future.”

Within Life Sciences, the company is focused on supporting pharmaceutical and academic scientific advancement from the earliest stage of discovery. In Diagnostics, the company develops new assays, systems, and complete workflows to help better diagnose disease.

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free